Nanoparticle Contract Manufacturing Market
完整報告名稱與涵蓋範圍
Nanoparticle Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Nanoparticles (Metal Nanoparticles, Lipid Nanoparticles, Others), By Manufacturing Scale (Commercial, Clinical, Pre-clinical), By Application (Therapeutics, Diagnostics, Vaccines), By End-user (Pharmaceutical Companies, Biotechnology Companies), By Region, And By Segment Forecasts, 2024-2031
報告摘要
The Nanoparticle Contract Manufacturing Market on a global scale was estimated at USD 2.4 Bn in 2023 and is set to attain USD 4.3 Bn by 2031, with a projected CAGR of 7.8% between 2024 and 2031.
At its core, Nanoparticle Contract Manufacturing pertains to the outsourcing of the production of nanoparticles to specialized companies equipped with the expertise, technology, and facilities to create and manipula. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by expanding requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanoparticle Contract Manufacturing Market Snapshot
Chapter 4. Global Nanoparticle Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Nanoparticles Estimates & Trend Analysis
5.1. by Type of Nanoparticles & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Nanoparticles:
5.2.1. Metal Nanoparticles
5.2.2. Lipid Nanoparticles
5.2.3. Others
Chapter 6. Market Segmentation 2: by Manufacturing Scale Estimates & Trend Analysis
6.1. by Manufacturing Scale & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Manufacturing Scale:
6.2.1. Commercial
6.2.2. Clinical
6.2.3. Pre-clinical
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Therapeutics
7.2.2. Diagnostics
7.2.3. Vaccines
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
Chapter 9. Nanoparticle Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.1.2. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.1.3. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.1.4. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.1.5. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.2.2. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.2.3. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.2.4. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.2.5. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.3.2. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.3.3. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.3.4. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.3.5. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.4.2. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.4.3. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.4.4. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.4.5. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.5.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.5.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.5.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.5.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AstraZeneca
10.2.2. Evonik Industries AG
10.2.3. Ascendia Pharmaceuticals
10.2.4. Axolabs (LGC Limited)
10.2.5. AVANSA Technology & Services
10.2.6. Ardena Holding NV.
10.2.7. Cytodiagnostics, Inc.
10.2.8. American Elements
10.2.9. Encapsula NanoSciences LLC
10.2.10. Fortis Life Sciences
10.2.11. Hongwu International Group Ltd.
10.2.12. MyBiotech
10.2.13. Nanochemazone
10.2.14. CordenPharma
10.2.15. LSNE Contract Manufacturing
10.2.16. Polymun
10.2.17. TeachNanoIndia
10.2.18. BIOVECTRA
10.2.19. Precision NanoSystems
10.2.20. Emergent BioSolutions
10.2.21. Other Prominent Players
10.2.22. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們